XMD-17-51
CAS No. 1628614-50-5
XMD-17-51( XMD17-51 )
Catalog No. M23725 CAS No. 1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 50MG | 1782 | In Stock |
|
| 100MG | 2250 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXMD-17-51
-
NoteResearch use only, not for human use.
-
Brief DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsXMD17-51
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorNUAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628614-50-5
-
Formula Weight404.47
-
Molecular FormulaC21H24N8O
-
Purity>98% (HPLC)
-
SolubilityDMSO:75 mg/ml (185.43 mM); Ethanol:10 mg/ml (24.72 mM); Water:2 mg/ml (4.94 mM)
-
SMILESO=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AMPK activator 12
AMPK activator 12 is an AMPK activator and GDF15 inducer that elevates the expression level of GDF15 protein in human hepatocytes, which can be used for cancer research.
-
BC1618
BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.
-
A-769662
A small molecule AMPK activator that directly stimulates partially purified rat liver AMPK (EC50=0.8 uM) and inhibits fatty acid synthesis in primary rat hepatocytes (IC50=3.2 uM).
Cart
sales@molnova.com